Patents/Assignees

NUVATION BIO Inc.

7 patents in portfolio

US12398121utility2025
Anti-cancer Nuclear Hormone Receptor-targeting Compounds
0 cites
US12208141utility2025
Anti-cancer Nuclear Hormone Receptor-targeting Compounds
0 cites
US12006314utility2024
Anti-cancer Nuclear Hormone Receptor-targeting Compounds
0 cites
US11952349utility2024
Anti-cancer Nuclear Hormone Receptor-targeting Compounds
0 cites
US11834458utility2023
Anti-cancer Nuclear Hormone Receptor-targeting Compounds
0 cites
US11826430utility2023
Anti-cancer Nuclear Hormone Receptor-targeting Compounds
0 cites
US11584756utility2023
Heterocyclic Compounds as BET Inhibitors
0 cites